Vanda Pharmaceuticals (VNDA) Tops Q3 EPS by 35c
Tweet
Share
E-mailGet Alerts VNDA Hot Sheet
Price: $5.03 -3.08%
Financial Fact:
Intangible asset amortization: 2.94M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Intangible asset amortization: 2.94M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Vanda Pharmaceuticals (NASDAQ: VNDA) reported Q3 EPS of ($0.04), $0.35 better than the analyst estimate of ($0.39). Revenue for the quarter came in at $14.8 million versus the consensus estimate of $12.2 million.
For earnings history and earnings-related data on Vanda Pharmaceuticals (VNDA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Ideal Power (IPWR) Tops Q2 EPS by 2c
- Azitra, Inc. (AZTR) Tops Q2 EPS by 54c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
